I. Neveu et al., 1,25-DIHYDROXYVITAMIN D-3 REGULATES THE SYNTHESIS OF NERVE GROWTH-FACTOR IN PRIMARY CULTURES OF GLIAL-CELLS, Molecular brain research, 24(1-4), 1994, pp. 70-76
The effect of 1,25-dihydroxyvitamin D-3 (1,25-(OH)(2) D-3) On nerve gr
owth factor (NGF) synthesis was investigated in primary cultures of as
trocytes prepared from brain of neonatal rats. 1,25-(OH)(2) D-3 elicit
ed a dose-dependent increase of NGF mRNA with a maximal effect at 10(-
7) M, which persisted for at least 48 h. Northern blot analysis reveal
ed an expression of the vitamin D-3 receptor (VDR) gene in primary gli
al cells. Treatment of cells with 1,25-(OH)(2) D-3 led to an increase
in the VDR mRNA levels. Similar results were obtained in C6 glioma cel
ls. Exposure of primary glial cells to 10(-8) M 1,25-(OH)(2) D-3 cause
d only a 2-fold increase of the levels of cell-secreted NGF after 3 da
ys of treatment. However, a 5-fold increase was observed three days af
ter a second addition of vitamin D-3. Likewise, a pretreatment with lo
wer doses of hormone such as 10-(10) M or 10(-9) M enhanced the respon
siveness of the cells to a 24 h treatment with 10(-8) M hormone. It ap
pears, therefore, that the duration of the treatment influences the le
vel of synthesis of NGF, possibly as a consequence of the increase of
the VDR gene expression. The specificity of 1,25-(OH)(2) D-3 is suppor
ted by the fact that a concentration of 10(-7) M of an another vitamin
D-3 metabolite, 24,25-(OH)(2) D-3, had no effect on NGF synthesis. Se
veral lines of evidence indicate that astrocytes constitute the major
cell type responsive to 1,25-(OH)(2) D-3 in primary cultures of glial
cells. Firstly, the removal of microglial cells or oligodendrocytes di
d not modify the time-course and amplitude of the response to 1,25-(OH
)(2) D-3. Secondly, 1,25-(OH)(2) D-3 had no effect on the synthesis of
NGF in meninge-derived fibroblasts. Thirdly, an 1,25-(OH)(2) D-3-depe
ndent increase of NGF mRNA was also found in C6 glioma cells. In concl
usion, the results suggest that 1,25-(OH)(2) D-3 may control the synth
esis of NGF in the central nervous system, and strongly support the in
volvement of 1,25-(OH)(2) D-3 as a mediator of astrocytic plasticity.